Skip to content

Clinical study on genotype and phenotypic characteristics of Gitelman syndrome

Clinical study on genotype and phenotypic characteristics of Gitelman syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048977
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gitelman syndrome

Interventions

Case series:None

Sponsors

PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The clinical manifestations are infection or skeletal deformity, short stature, muscle weakness, etc.; 2. Children with low or normal blood pressure; 3. Children with chronic hypokalemia (blood K+ concentration <3.50mmol/L) accompanied by renal potassium loss; 4. With or without hypomagnesemia (blood Mg2+ concentration <0.66mmol/L); 5. Hypocalciuria [urine 24hCa2+ concentration <0.1mmol/(kg??d) or single urine Ca2+ concentration/creatinine concentration <0.21; 6. Metabolic alkalosis; 7. RAAS system activation (increased plasma renin, angiotensin, aldosterone levels or increased activity).

Exclusion criteria

Exclusion criteria: 1. Long-term use of laxatives and diuretics; patients with primary or secondary glomerulonephritis, nephrotic syndrome and other diseases; 2. Combined with other chronic diseases, such as hypothyroidism, growth hormone deficiency and other diseases.

Design outcomes

Primary

MeasureTime frame
Disease genes;

Countries

China

Contacts

Public ContactXiao Donghua

Chinese People's Liberation Army General Hospital

hsdcyq@163.com+86 13581850756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026